NCT00365768View on ClinicalTrials.gov

Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Kidney CancerLeukemiaLymphomaNeurotoxicityPeripheral NeuropathySarcoma
Interventions
DRUG

Glutamine

Administered orally twice daily for 21 days

OTHER

Placebo

Administered orally twice daily for 21 days

Trial Locations (1)

10032

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT00365768 - Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors | Biotech Hunter | Biotech Hunter